18 March 2026 - Alebund Pharmaceuticals, a China-based, renal-focused biopharmaceutical company, announced on Tuesday that it has signed licensing and equity agreements with R1 Therapeutics Inc, a newly launched clinical-stage biotechnology company.R...
18 March 2026 - Abzena, an end-to-end integrated contract development and manufacturing organisation (CDMO) for complex biologics and bioconjugates, announced on Tuesday it has been named a leader in the Frost Radar Report for Antibody-Drug Conjugate...
18 March 2026 - Apertura Gene Therapy, a biotechnology company developing next-generation adeno-associated virus (AAV) capsids for delivering genetic medicines, has formed a strategic manufacturing collaboration with Viralgen, a contract development ...